pharmacy daily for thu 16 may 2013 - shpa blasts 5cpa, gsk, kava, generics survey and much more
TRANSCRIPT
7/30/2019 Pharmacy Daily for Thu 16 May 2013 - SHPA blasts 5CPA, GSK, Kava, generics survey and much more
http://slidepdf.com/reader/full/pharmacy-daily-for-thu-16-may-2013-shpa-blasts-5cpa-gsk-kava-generics 1/3
Thursday 16 May 2013 PHARMACYDAILY.COM.AU
Pharmacy Daily Thursday 16th May 2013 t 1300 799 220 w www.pharmacydaily.com.au page 1
“The Times Are A-Changin” (Bob Dylan 1964)
What is your pharmacy worth in today’s market?
Free and Condential Appraisal
Email: [email protected] or Freecall: 1800 670 440
Australia’s largest & longest established
pharmacy brokerEstablished since 1987
Pharmacy Sales
38GROUP 2
U P T O
CPD CREDITS
31 May – 2 June 2013Connecting practice to patient outcomes
2013
CPExpo
www.psa.org.au/cpexpo
Snoreben for snoring
BENSON Medical Services isy p Sb
puc, ufcu Au
c -uc u
hp p bh b
p h.
It’s registered as a Class 1 Medical
Dc wh h TGA h FDA -
f pe ree.
$41m prot for GSK
glaxOSmithkliNE says thec Ph uy pp b
cyc, p
2012 u h wk.
GSK’ 2012 Au
u $1.452 b,
wh w up y
, wh 9% wh xp
$521 , h $41 p-x
p w w u ch
h Phcuc bu.
Th ch uy PBS
f w GSK f f
Cc B (cp
25 -p cpuc) pu OTC b
Ap ucu Vc-
b phcuc .
“Ou pp f w c
h h p f GSK’
fuu uch h
f h b w u fcu
b w c
Au p,” G
McD, GSK’
Phcuc Au.
Th Cu Hhc
w $355, wh 18%
wh P O
pfc f pc
hh b, wh
h Op wh
f c ppp
cu xp.
SHPA blasts Guild, 5CPAthE Scy f Hp
Phc f Au y
h wk’ cy h
S C p
chhpy (PDM) h
h ck f pcy
uu h Fh Cuy
Phcy A.
I u yy,
the Society said that despite
h Gu’ u h
ch fu p f h
, “h S C
fu h h pp h Gu’ w uc
hw h bw
h Cwh h Gu
w u cu
chhpy fu, h
y qu upp
chhpy c hu b
fu f wh h 5CPA”.
Th SHPA h hw h
“ h f
fu f phcy c
huh
by phcy
hc.
“I h p y
the chemotherapy issue we have
c HMR fu,
y p h hp
f phwy f HMR, h
c u CE wc
cc Gup 2 CPD,” h
.
I pcu, h SHPA h
c h c h
f Au cu, h
Au hhc y
h phcy pf wh “ by
phcy wh
bhp c.”
Th Scy b h
phcy
c quy p h
pf h
f cu c c
wh c upp.
mEaNWhilE h
chhpy u, h SHPA
y h cu bu u
c bw p
b h whp f h
phcy h hp wh
they are treated.
SHPA h pp “ p ”
h cy h fu
cp c f chhpy:
h c f h c, h c f
cub, h pp
cu f, phcy
pf c f.
Th pp cu
f h bu u f
PBS c, cu h
Chhpy Phcuc
Acc P (CPAP) bh
pubc p hp
pharmacy providers.
SHPA y w k wk wh
DHA h $1.2 chhpy
w (PD yy) u h
c c b “by
quy fu.”
Kava anxiety studya UNiVERSitY f Mbu
uy pubh h Journal
of Clinical Psychopharmacology h p w-
c whch fu h K
cy uc h yp
f pp u xy.
Ppu Suh Pcc
b, K
c p whch “
p u
h f chc
c xy,” cc
esearcher, Dr Jerome Sarris.
“Uk h p h
k f pcy
p f c”.Th uy w fu by h
NHMRC I Hhc,
h ufcu f MHb
Thp’ K puc.
Pradaxa DAA alertNPS Mcw h
phc h b
Px) hu b p
pck y,
pc f u huy.
Rpck DAA c
xp h cpu u
huy, puc
bkw f pcy.
Script RefillScript Ready Last Repeat
Increase patient loyalty & patient compliance
PLUS Automatically groupsSMS reminders when multiplemedications are due AND Software prompts youwhen patient replies.
Sign up today! Click hereContact us on 1300 734 869 or email
7/30/2019 Pharmacy Daily for Thu 16 May 2013 - SHPA blasts 5CPA, GSK, Kava, generics survey and much more
http://slidepdf.com/reader/full/pharmacy-daily-for-thu-16-may-2013-shpa-blasts-5cpa-gsk-kava-generics 2/3
Thursday 16 May 2013 PHARMACYDAILY.COM.AU
ditors Buc Pp K M email [email protected] advertising M Hzk email @phcyy.c.u page 2rmacy Daily is a publicaon for health professionals of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain wrien permission from the editor to reproduce any material. While every care has been taken in the
preparaon of Pharmacy Daily no liability can be accepted for errors or omissions. Informaon is published in good faith to smulate independent invesgaon of the maers canvassed. Responsibility for editorial is taken by Bruce Piper.
DISPENSARYCORNER
STOP TYPING START SCANNING
F a s t e r Dispensi n g
eRx means faster dispensing and fewer errors
ONE y p y b
f hy w, wh
c Bz c p
ch p p
u.
I xp h ch
c yhc p,
whch pc bb f
h c f h p f h
Lxc p whch ch y
hospitalises almost 7,000 peopleuy.
Th p h Vaccine ju
h bb whch w
u u h p w
pc f k
h f h p b, w
f hh.
UNiCEF h cy c
h y f Nh Tw
h Pcc ’
“p fc-f” ODF
.
Nh Tw p f Kb,
h ppu f bu
5,000 pp - f wh
u p h bch.
UNICEF pkw Nuzh
Shhz h w
j bkhuh f h
, wh up 70% f
pp y cu
pcc p fc.
“Nh Tw I c k
fw c uc
h w
f u y
u,” h .Kb p A T
h f Dcb
2015 f h cuy
bc ODF.
thE k f ppu Bh
puc h uch
pc up whch
“uhy cck”.
Py, whch u
pp w f p,
h h hh,
cu wb pc h
wearer’s modesty.
A h cpy p uy whch fu h
B xp bck
h h wk,
wh bu h cup.
WELCOME to Pharmacy Daily ’stravel feature. Each week wehighlight a couple of great traveldeals for the pharmacy industry,brought to you by Cruise Weekly.
SavingS of up to $4,470 percouple are available on a seriesof Discover the World Cruisingitineraries this year.
The ‘two for one’ cruisefares are oered on the 8 day
Romantic Rivieras cruise inFrance and Italy, as well as the 8
day Treasures of South Italy and Malta, for selected departures inJune, August and October 2013.
The trips are aboard the 67metre Variety Voyager megayacht - call 1800 623 267.
trve Specs
Sp by Cruise Weekly
yu FREE cu w
Subcb w
www.cruseweey.co.u
WIN AN INNOXA BEAUTY
ESSENTIALS PACK
This week Pharmacy Daily is
giving five lucky readers the
chance to win an Innoxa beauty
essentials pack including classic
and new products across the
Innoxa range.
NEW Innoxa Anti-Ageing &
Firming facial serum – improves
skin complexion to promote
radiant looking skin. Specially
formulated with anti-ageing
ingredients to help fight signs of
ageing.
NEW Antioxidant lip glaze – a nourishing lip glaze with high gloss
and shine contains botanical and antioxidant rich ingredients to
repair and condition lips.
To win this great prize, be the first person to send in the correct
answer to the question below to: [email protected].
Which Innoxa Foundation has
5 benefits in 1?
Congratulations to yesterday’s lucky winner, Lindsay Scott from
Broken Hill Health Service.
Which Innoxa Foundation has
5 benefits in 1?
Consumers want genericsa SigNiFiCaNt jy f
cu uy c p
f phcy cu hy
wy ch h c f
c f w b.
Th C Bu-c
uy u p f
1900 Au wh h
made a pharmacy purchase over
h x h.
“A h qu f h
p u uy hy
b pcp c
w xp,” CBu pkp Rbcc L.
“R u w
h 70% wy ch h c
...c b
chp h h b
,” h .
“A fuh, 76% huh
hy hu h py f
a doctor’s visit to have a script
w,” L .
Oh u f h
uy w h h f
p hy kw h
phc by ,
h hf k c f h
phc wh -h-
cu c hy cu k
bf c’ .
30% hy pf ‘f-
c’ h c’
surgery.
The survey also highlighted
c bw
phc up, wh 36% f
‘Bby B’ c bu
k f c c
h phcy, c wh ju
10% f ‘G Y’ cu.
Bby B w hf ky
G X Y p f-c (20%, u 41%
42% pcy).
FDA approvalsthE US F Du
A h pp
h cb EGFR Mu T,
cp c f h
cc u Tc (b).
I’ h FDA-pp
cp c whch
c p wh fc
cp (EGFR) u,whch p bu 10% f
--c u cc.
Th b pp wh
xp u f Tc -
f p wh
h cc wh h c
u h EGFR .
Th FDA h pp
f Nuz, w p
u p
xpc yp u
f ubch hh.
Np w puy y
b qu- cp.
€40.6m Sano neSaNOFi h b py
€40.6 p f “
cp” Fc
c f Px.
Th Fch cp uhy
h S’ fc
cc h c wh k
wh phc c
2009 2010, w u
c pc w
ubu pcp.
Px w h cy
c f Fc’ hh y
2008, c €625.
S ’ “w h
p pp pp”.
7/30/2019 Pharmacy Daily for Thu 16 May 2013 - SHPA blasts 5CPA, GSK, Kava, generics survey and much more
http://slidepdf.com/reader/full/pharmacy-daily-for-thu-16-may-2013-shpa-blasts-5cpa-gsk-kava-generics 3/3
SNOREBEN – Medical Device Class One!
NOW AVAILABLE!
“BREATHE BETTER & SLEEP BETTER EVERY NIGHT, WAKE UP REFRESHED EVERY DAY!!!”
SNOREBEN© *Is an proudly Australian manufactured invention. Is an effective, non‐surgical solution for anyone who has
nasal disorder such as: allar collapse (collapsed nostrils), deviated septum (bent nose), damaged nostrils and narrow
nostrils and will safely keep nasal passages open, allowing everyone to breathe freely through the nose.
PRODUCT RANGE: *For men & women only.
FEATURES AND BENEFITS:
Effectively helps in reducing/preventing snoring, as well improving sleep apnea, nasal congestion, dry mouth and
allergies.
Recommended by Ear, Nose & Throat Doctors in Australia and around the globe to help anyone at any age breathe
better and sleep better every night.
Continuously reusable for 30 days guaranteed.
100% latex free, skin allergy free.
Safe to use, comfortable fit and very soft and gentle to the skin.
Manufactured from high-quality, soft medical grade materials.
Registered as a Class 1 Medical Device with Therapeutic Goods Administration-Australia & Food and Drug
Administration-USA.
Recommended to read product instruction before use!
See our website: www.BenMedical.com.au or see our representative contact details below.
All Enquiries:
Landmark Agencies Australia Pty Ltd
Phone/Fax: 02 4704 8187
Mobile: 0430 214 521
Address: PO BOX 7276, Penrith South, NSW, 2750
Email: [email protected]
www.landmarkagencies.com.au